Florida and medical marijuana just aren’t quite meshing right now, but we’re working on getting it all straight soon:
This just in over the weekend from MJ Biz, “House Majority Leader Steny Hoyer, a Maryland Democrat, intends to put the SAFE Banking Act to a vote before the end of September, a staff member confirmed to Marijuana Business Daily on Friday.”
The bill submitted requires the attorney general to move cannabis from Schedule I to Schedule III under the Controlled Substances Act, with the aim of increasing research on the drug’s effects.
Rusty Rumley, senior staff attorney for the National Agricultural Law Center, will outline the current regulatory landscape for industrial hemp in a Sept. 18 webinar that starts at noon. There is no cost to attend the webinar.
It’s taken a long time for a firm to stand up at the front of the queue and say this. It can only be to their advantage. This past week’s vape crisis is just the first of many we’d suggest.
For those of you in the dark about Florida’s Medical Marijuana Program, I’ve been attempting to light up the dim corners of Florida: The Nation’s Fastest-Growing Medical Marijuana Market, according to The Miami New Times.
Joy A. Strand, the executive director of the Maryland Medical Cannabis Commission, has resigned, the Baltimore Sun reports.
Professor McMillan’s Final Report on the Review of the Act was tabled in the Australian Parliament, Thursday 5 September 2019. The main recommendation, “Amend the Act once again to establish a single licence scheme for cannabis production.”
The rules, set to take effect in October say cannabis edibles will have a limit of 10 mg of THC per package.
They write, “Marijuana Business Daily obtained a copy of the draft rules ahead of their release from a source who requested anonymity. The proposals are subject to change.”